MYC is commonly dysregulated in many high-grade B cell malignancies, including GC-derived lymphomas such as Burkitt lymphoma (BL) and diffuse large B cell lymphoma (DLBCL; ref. 7). Here, MYC is linked to diffuse large B-cell lymphoma.